Lexagene Holdings Stock EBITDA
| LXXGFDelisted Stock | USD 0.08 0.00 0.00% |
Lexagene Holdings fundamentals help investors to digest information that contributes to Lexagene Holdings' financial success or failures. It also enables traders to predict the movement of Lexagene OTC Stock. The fundamental analysis module provides a way to measure Lexagene Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexagene Holdings otc stock.
Lexagene |
Lexagene Holdings OTC Stock EBITDA Analysis
Lexagene Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Lexagene Holdings EBITDA | (10.04 M) |
Most of Lexagene Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexagene Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Lexagene Holdings reported earnings before interest,tax, depreciation and amortization of (10.04 Million). This is 101.14% lower than that of the Healthcare sector and 101.56% lower than that of the Medical Devices industry. The ebitda for all United States stocks is 100.26% higher than that of the company.
Lexagene EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexagene Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Lexagene Holdings could also be used in its relative valuation, which is a method of valuing Lexagene Holdings by comparing valuation metrics of similar companies.Lexagene Holdings is currently under evaluation in ebitda category among its peers.
Lexagene Fundamentals
| Return On Equity | -3.4 | |||
| Return On Asset | -1.2 | |||
| Operating Margin | (81.65) % | |||
| Current Valuation | 17.25 M | |||
| Shares Outstanding | 140.64 M | |||
| Shares Owned By Insiders | 17.86 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Earning | (6.07) X | |||
| Price To Book | 7.05 X | |||
| Price To Sales | 130.07 X | |||
| Revenue | 75.31 K | |||
| Gross Profit | (468.03 K) | |||
| EBITDA | (10.04 M) | |||
| Net Income | (10.96 M) | |||
| Cash And Equivalents | 1.09 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 996.65 K | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 2.91 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.66 M) | |||
| Earnings Per Share | (0.09) X | |||
| Target Price | 1.83 | |||
| Number Of Employees | 33 | |||
| Beta | 2.04 | |||
| Market Capitalization | 26.44 M | |||
| Total Asset | 8.2 M | |||
| Z Score | 12.3 | |||
| Net Asset | 8.2 M |
About Lexagene Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lexagene Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lexagene Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lexagene Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Lexagene Holdings information on this page should be used as a complementary analysis to other Lexagene Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Lexagene OTC Stock
If you are still planning to invest in Lexagene Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexagene Holdings' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |